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Abstract In cell signaling cascades, one stimulus often leads to
various physiological functions by multiple pathways. Perturba-
tion of one pathway by blocking or overexpressing one of its
components will result in changes in multiple pathways and
multiple cell functions. Thus, it is important to reveal the rela-
tive contribution of each pathway to each function in order to
assess the consequence of perturbations (e.g. drug delivery). By
exploring an established mathematical model, the Shc-depen-
dent pathway is found to be both redundant and dominant dur-
ing activation of the mitogen-activated protein kinase cascade
by epidermal growth factor receptor (EGFR). Its dominance
results from the majority consumption of the common precursor
((EGF-EGFR*)2-GAP) by this pathway. The key steps for the
dominance are the binding and phosphorylation of Shc. In con-
clusion, cells may prefer the long Shc-dependent pathway to the
short Shc-independent pathway.
+ 2003 Published by Elsevier B.V. on behalf of the Federation
of European Biochemical Societies.
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1. Introduction
The epidermal growth factor receptor (EGFR) is one of the
tyrosine kinase receptors and is involved in various physio-
logical or pathological phenotypes including embryonic and
postnatal development [1], progression of tumors [2], and
transactivation processes [3]. Upon being bound by the ligand
EGF at the extracellular domain, EGFR forms a dimer and
phosphorylates itself at the intracellular domains. Phosphor-
ylated EGFR then recruits a series of signaling molecules and
induces activation of mitogen-activated protein kinase
(MAPK) cascade [4]. The activated MAPK then regulates
several cellular proteins and nuclear transcription factors [5].
There are two pathways used by EGFR to activate the
MAPK cascade, Shc-dependent and Shc-independent [6,7].
Although Shc-mediated MAPK activation has been well es-
tablished [8,9], dominant negative Shc or loss of Shc expres-
sion often results in only a partial loss of MAPK activation
[10]. It remains unclear how much Shc contributes to MAPK
activation. Recently a computational model for the dynamics
of MAPK cascade activation by EGFR was proposed [11],
which provided an insight into signal^response relationships
between the ligand binding and activation of downstream
proteins in the signaling cascade. However, the report did
not address the issue of the relative contribution of Shc-de-
pendent and -independent pathways. In this study, we further
explore the model to quantitatively assess the relative contri-
bution of the Shc-dependent and Shc-independent pathways
to MAPK activation by EGFR. We report here that the Shc-
dependent pathway is both dominant and redundant during
activation of MAPK by phosphorylated EGFR. The redun-
dancy is supported by several experimental results in the liter-
ature, and the key step responsible for the dominance is re-
vealed in this study. Furthermore, the sub-pathways within
the Shc-dependent pathway are dissected mathematically
and their contributions to MAPK activation are discussed.
As more and more signaling cascades are revealed to utilize
multiple pathways (see the review by Liebmann [12]), the pro-
tocol demonstrated in this study for assessing their relative
contributions will have a broad usage in simulating cell signal
transduction and inferring the biological importance of alter-
native pathways.
2. Model and simulation
The model described by Schoeberl et al. [11] was used in this study.
The scheme of the EGFR-induced MAPK cascade was modi¢ed so
that each molecule species appears only once (Fig. 1). The Shc-depen-
dent and Shc-independent pathways are separated graphically so that
the components in each pathway are readily identi¢ed. The two path-
ways share the same events at the beginning, i.e. binding of EGF to
EGFR, dimerization and phosphorylation of EGFR, and recruiting of
GAP (not shown in Fig. 1). They diverge at the point of (EGF-
EGFR*)2-GAP. Instead of Grb2, Shc is recruited in the Shc-depen-
dent pathway. After phosphorylation of Shc, Grb2 is recruited to
form (EGF-EGFR*)2-GAP-Shc*-Grb2, which is the equivalent of
(EGF-EGFR*)2-GAP-Grb2 in the Shc-independent pathway (Fig.
1). The following common events are SOS binding and then Ras-
GDP binding. The two pathways converge at the point of Ras-GTP
production, and thereafter follow the same track to sequentially acti-
vate Raf, MEK and ERK (not shown in Fig. 1).
Simulation was conducted using the biochemical simulator GEPA-
SI version 3.21 [13^15] The reactions, their kinetic parameters and the
initial quantities of the components were input into GEPASI using its
GUI (graphical user interface). Totally there were 125 reactions and
94 components, as described by Schoeberl et al. [11].
For assessing the relative contributions of the two or more path-
ways, the concentrations of the components are of limited values.
Molecules may be produced and consumed at the same time. If
both processes occur in the same strength, the concentration of a
molecule remains constant. More importantly, the concentration is
component (molecule species)-speci¢c and does not re£ect the contri-
bution of a single reaction. Thus, it is more meaningful to observe
production and consumption of each component dynamically via each
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reaction in which it is involved for the purpose of this study. To do
so, the £uxes (velocity of the molecular £ow, which is reaction-specif-
ic) of the reactions were traced. This function is one of the features of
the software GEPASI. The amounts of molecular £ow (which is re-
action-speci¢c, accordingly) were calculated with integration over the
simulation time, using the following formula: molecular £ow=
g(vtUFt), where vt is the small segment of time (typically 1 s in
this study) and Ft is the £ux at time t (in the unit of M/s). With
molecular £ows, it is easy to dissect the ratio of a component pro-
duced by di¡erent reactions, or the £ows of a component into di¡er-
ent reactions.
For reversible reaction steps, unidirectional arrows are used in the
scheme for assignment of the forward and reverse reactions. The £ux
value can be positive or negative. When the value of the £ux is pos-
itive, the £ow of the molecule has the same direction as the arrow. If
the value of the £ux is negative, the molecular £ow has a reverse
direction to the arrow.
3. Results
It has been modeled previously that EGFR could be inter-
nalized before or after activation, and the internalized recep-
tors transduce signal as well [11]. However, internalization of
the receptors had very limited e¡ects on production of Raf,
MEK-PP and ERK-PP under the simulation condition used
in this study (with 50 ng/ml EGF) (data not shown), which
was in agreement with the published results [11]. Therefore,
the e¡ects produced by both cell surface and internalized re-
ceptors were combined for the simulation in this study.
The relative contribution of the Shc-dependent and Shc-in-
dependent pathways to MAPK activation was ¢rst assessed.
The index of contribution was evaluated by the molecular
£ow to Ras-GTP from its direct precursors ((EGF-
EGFR*)2-GAP-Shc*-Grb2-Sos-Ras-GDP and (EGF-
EGFR*)2-GAP-Grb2-Sos-Ras-GDP for the Shc-dependent
and Shc-independent pathways, respectively). The £uxes of
the reactions were traced up to 60 min and production of
Ras-GTP was calculated. As shown in Fig. 2, the Shc-depen-
dent pathway was the dominant one used by EGFR to pro-
duce Ras-GTP, while only 2% of the total Ras-GTP was
produced by the Shc-independent pathway, when the initial
concentration of EGF was set at 50 ng/ml and the concentra-
tion of Shc at the reported value [11].
To further determine the extent to which the Shc-dependent
pathway was dominant and also whether it was redundant as
indicated by several experiments, the e¡ects of initial Shc con-
centration on Ras-GTP production by the two pathways were
tested, using the component concentration perturbation scan-
ning, a function provided by GEPASI. The total production
Fig. 1. Partial scheme of the EGFR-induced MAPK cascade. This ¢gure aims to show the Shc-dependent and Shc-independent pathways. The
Shc-dependent pathway is located on the left part, whereas the Shc-independent pathway is located on the right part. The common precursor
of, convergent point of, possible cross-talks between the two pathways, and several initial components are located in the middle of the scheme.
Each component label represents a molecular species at the cell surface, and internalized as well, if applicable. Arrows represent the reaction di-
rection. In the case of a reversible reaction, the direction of the arrows determines the forward and reverse reaction parameters, which is not
shown in the scheme. The IDs for the reactions begin with letter v and are close to the arrows representing the reaction. For simpli¢cation,
only the IDs of the reactions being discussed are displayed. In the case of two IDs, the second one represents the reaction with the internalized
component. (Modi¢ed from [11].)
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of Ras-GTP only had a small reduction (less than 5%) when
the initial Shc concentration was set at 0. Under this condi-
tion, all of the Ras-GTP was produced via the Shc-indepen-
dent pathway (Fig. 3). This result suggested that the Shc-de-
pendent pathway was redundant in the MAPK activation by
EGFR. Nevertheless, the existence of a small amount of Shc
(6 12% of the reported value) would restore Ras-GTP pro-
duction almost to a normal level (s 99%). Furthermore, this
small amount of Shc caused the Shc-dependent pathway to
produce more than 83% of the total Ras-GTP. When the Shc
level was half of the reported value, this ratio was as high as
95% (Fig. 3), indicating that a low level of Shc was enough to
make this pathway dominate MAPK activation.
There are at least two possible scenarios for the dominance
of the Shc-dependent pathway. One is the cross-talk between
the pathways (see Fig. 1). The early components in the Shc-
independent pathway may be produced in a considerable
amount, but consumed by the cross-talk paths between the
pathways, instead of leading to production of Ras-GTP via
their own pathway. Alternatively, most of the common pre-
cursor of the two pathways ((EGF-EGFR*)2-GAP) is con-
sumed by the Shc-dependent pathway in the presence of
even a very small amount of Shc. To test these two possibil-
ities, consumption of the common precursor ((EGF-
EGFR*)2-GAP) by the two pathways was compared by trac-
ing the £uxes from the common precursor and calculating the
molecular £ows. As shown in Fig. 4, a majority of the pre-
cursor (99.9%) £owed to the Shc-dependent pathway. To rule
out the possibility of cross-talk, production of the intermedi-
ates equivalent in the two pathways ((EGF-EGFR*)2-GAP-
Shc*-Grb2 vs. (EGF-EGFR*)2-GAP-Grb2, (EGF-EGFR*)
2-GAP-Shc*-Grb2-Sos vs. (EGF-EGFR*)2-GAP-Grb2-Sos,
(EGF-EGFR*)2-GAP-Shc*-Grb2-Sos-Ras-GTP vs. (EGF-
EGFR*)2-GAP-Grb2-Sos-Ras-GTP, and (EGF-EGFR*)
2-GAP-Shc*-Grb2-Sos-Ras-GDP vs. (EGF-EGFR*)2-GAP-
Grb2-Sos-Ras-GDP; see also Fig. 1) was also compared.
There was no signi¢cant production of the intermediates in
the Shc-independent pathway in comparison with their coun-
terparts in the Shc-dependent pathway (data not shown).
Thus it is concluded that the existence of Shc caused the
common precursor ((EGF-EGFR*)2-GAP) £ow to the Shc-
dependent pathway, consequently leading to the dominance of
the Shc-dependent pathway in Ras-GTP production.
A question remains as to which step(s) along the Shc-de-
pendent pathway determines the majority £ow of the common
precursor to this pathway and subsequently production of
most Ras-GTP. A systematic scanning of the parameters of
all the reactions involved in the Shc-dependent pathway was
conducted, taking advantage of the power of GEPASI for
parameter perturbations. The results showed that changes in
three of the parameters could signi¢cantly a¡ect production of
Ras-GTP by the Shc-dependent pathway. They were v22k1
(forward rate constant of the reaction v22), v23k1 and v26k1
(Fig. 5A^C; also see Fig. 1 for their locations). Changes of
parameters in all other forward reactions and all reverse re-
Fig. 2. Relative contributions of the Shc-dependent and Shc-inde-
pendent pathways to production of Ras-GTP. The y-axis represents
the molecular £ow to Ras-GTP. The simulation was conducted us-
ing the same set of reaction parameters and initial concentrations as
described [11]. EGF concentration was 50 ng/ml. The time course of
£uxes for reactions v27(74) (in the Shc-dependent pathway) and
v19(66) (in the Shc-independent pathway) were traced for 60 min
with 1 s for each segment. The £uxes from reactions v27 and v74,
and from reactions v19 and v66, were combined, respectively. Mo-
lecular £ows were then calculated as the sum of the £uxes at each
time point.
Fig. 3. Relative contributions of the Shc-dependent and the Shc-in-
dependent pathways to production of Ras-GTP at varied initial Shc
concentrations. The y-axis represents the molecular £ow to Ras-
GTP. The simulation condition and calculation was the same as de-
scribed in Fig. 2, except that the Shc concentration was scanned.
The values of initial Shc concentrations were selected logarithmi-
cally, spanning from 0 to 1.68E-6 M.
Fig. 4. Amount of the common precursor, (EGF-EGFR*)2-GAP,
£owing to the Shc-dependent pathway via reactions v22 and v69
(combined and labeled as [22] in this ¢gure), and to the Shc-inde-
pendent pathway via reactions v16 and v63 (combined and labeled
as [16] here). The simulation condition was the same as described in
Fig. 2.
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actions did not a¡ect the di¡erential production of Ras-GTP
(data not shown). v22 is the ¢rst step from the common pre-
cursor in which Shc is bound, and v23 is the subsequent step
in which Shc is phosphorylated. Both v22 and v23 are speci¢c
to the Shc-dependent pathway. v26 is the step in the Shc-de-
pendent pathway in which the Ras-GTP precursor is pro-
duced and which has an equivalent in the Shc-independent
pathway (v18). Both v26 and v18 have the same values for
forward and reverse rate constants, suggesting that the key
steps determining the £ow of the common precursor are v22
and v23. Furthermore, as little as 0.05% of the reported v23k1
value, or 2% of the reported v22k1 value, resulted in the two
pathways producing the same amount of Ras-GTP (Fig.
5A,B). Further, the e¡ects of changes in v22k1 and v23k1
on the dynamics of the downstream ERK signal are also
di¡erent. When v22k1 or v23k1 was set at 0, the total Ras-
GTP production was almost unchanged (97.2%) or dropped
to 63.3% of the full amount, respectively (Fig. 5A,B). Inter-
estingly, when v26k1 was set at 0, the total Ras-GTP produc-
tion was reduced by 88% (Fig. 5C), suggesting that produc-
tion of Ras-GTP by the Shc-independent pathway did not
compensate the block of this step in the Shc-dependent path-
way. It was hypothesized that in this situation most common
precursor £owed to the Shc-dependent pathway and accumu-
lated as the intermediates in this pathway during the blockage
of reaction v26. The accumulation could be ful¢lled via, for
example, the loop: v22-v23-v37-v36-v22. This was con¢rmed
by tracing each reaction in this loop, where their £uxes were
signi¢cantly increased when v26k1 was set at 0 (data not
shown).
After quantitative dissection of the Shc-dependent and Shc-
independent pathways, the sub-pathways in the Shc-depen-
dent pathway were further dissected. In the Shc-dependent
pathway, there are two sub-pathways that possibly lead to
production of Ras-GTP. They are (also see Fig. 1):
1. (EGF-EGFR*)2-GAPC(EGF-EGFR*)2-GAP-
ShcC(EGF-EGFR*)2-GAP-Shc*C(EGF-EGFR*)
2-GAP-Shc*-Grb2C(EGF-EGFR*)2-GAP-Shc*-Grb2-
SosC(EGF-EGFR*)2-GAP-Shc*-Grb2-Sos-Ras-
GDPCRas-GTP;
2. (EGF-EGFR*)2-GAPC(EGF-EGFR*)2-GAP-
ShcC(EGF-EGFR*)2-GAP-Shc*C(EGF-EGFR*)
2-GAP-Shc*-Grb2-SosC(EGF-EGFR*)2-GAP-Shc*-
Grb2-Sos-Ras-GDPCRas-GTP.
Instead of reactions v24 and v25, (EGF-EGFR*)2-GAP-
Shc*-Grb2-Sos is produced directly from (EGF-EGFR*)2-
GAP-Shc* and Grb2-Sos via reaction v41 in the second
sub-pathway. This is independent of the ¢rst sub-pathway,
because Grb2-Sos is produced from pre-existing Grb2 and
Sos. A £ux-tracing experiment showed that, at ¢rst, both
sub-pathways were used to produce Ras-GTP. Reactions
v24 and v25 were reversed after 270 s and 126 s, respectively
(Fig. 6). Thereafter, only the second sub-pathway was used
(see the top curve in Fig. 7A). (EGF-EGFR*)2-GAP-Shc* is
the common precursor of the two sub-pathways. Its £ow to
the two sub-pathways depends on the value of v41k1 (Fig. 7).
At low v41k1, £ow to the ¢rst sub-pathway was always prev-
alent. At considerable v41k1, at ¢rst part of the common
Fig. 5. Relative contributions of the Shc-dependent and Shc-independent pathways to production of Ras-GTP at varied values of rate con-
stants. The y-axis represents the molecular £ow to Ras-GTP. The simulation condition was the same as described in Fig. 3, except the rate con-
stants were scanned instead of initial Shc concentration. Rate constant values were selected, and the x-axis values are displayed logarithmically.
A: Rate constant k1 of reaction v22 was scanned. B: Rate constant k1 of reaction v23 was scanned. C: Rate constant k1 of reaction v26 was
scanned. £ow_v19 and £ow_v27 represent the contribution of the Shc-independent and Shc-dependent pathways, respectively. The e¡ects of cell
surface and internalized receptors were combined.
Fig. 6. Time courses of the £uxes of reaction v24 (including v71)
and v25 (including v72). The simulation condition was the same as
described in Fig. 2 except £uxes for reactions v24 (and v71) and
v25 (and v72) were traced. At the beginning of the simulation, the
molecular £ows were towards Ras-GTP production. Then £uxes
were reversed and these reactions negatively contributed to Ras-
GTP production.
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precursor £owed to the ¢rst sub-pathway, then all the £ow
was through the second sub-pathway. At high v41k1, £ow to
the second sub-pathway was always prevalent (Fig. 7). How-
ever, as previously demonstrated, change in a single kinetic
parameter of reactions v24 or v25 or v41 did not a¡ect the
Ras-GTP production by the Shc-dependent pathway. Conse-
quently, blockage of either of the sub-pathways would not
a¡ect the dynamics of the Ras-GTP production by EGFR.
4. Discussion
Shc is an adapter protein, its tyrosine is phosphorylated by
several di¡erent types of receptors (growth factor receptors,
antigen receptors, cytokine receptors, G protein-coupled re-
ceptors and hormone receptors, for review see [10]). The
real role Shc plays in signal transduction is not clear. Two
possibilities have been proposed: Shc provides a central and
universal component of intracellular signaling, or the phos-
phorylation of Shc is a bystander e¡ect [10]. In MAPK acti-
vation by EGFR, Shc provides an alternative pathway [6,7].
The existence of the Shc-dependent pathway increases the
complexity of signal transduction networking. Although net-
working could contribute to genetic bu¡ering [16], i.e. the
robustness of the biochemical networking, the Shc-dependent
pathway in this currently used model might not be aimed at
this, based on the fact that this pathway shares all other signal
molecules with the Shc-independent pathway.
In this study we revealed computationally the redundancy
and dominance of the Shc-dependent pathway during MAPK
activation by EGFR. The structural basis for the redundancy
is the ability of phosphorylated EGFR to be bound by both
Shc (via the Shc SH2 and PI domains) and Grb2 (via the
Grb2 SH2 domain) as well as the binding of Grb2 to phos-
phorylated Shc (via the Grb2 SH2 domain) [6]. The redun-
dancy of Shc in EGFR signaling has been observed in several
types of cells, e.g. chicken DT40 B cell lines in which Shc was
knocked out [17], and rat pheochromocytoma cell line PC12
where the Shc inhibitor TRK-Y490P was used [18]. Shc re-
dundancy was also observed in several other situations. For
example, when proliferation or viability signaling was acti-
vated by granulocyte/macrophage colony-stimulating factor,
the tyrosine phosphorylation of Shc was not necessary [19].
In addition, Raf1 was activated by erythropoietin via the Shc-
independent pathway [20] and 8-bromo-cAMP induced a pro-
liferative response independent of Shc [21]. In contrast, Shc
was non-redundant in thymic T cell development [22]. Also,
mouse embryos with homozygous mutant at the ShcA locus
died at day 11.5 with severe defects in heart development [9].
Obviously, the situations at the cellular or whole animal levels
are much more complex than the model used in this study.
The complexity comes, at least, from the multiple pathways
Shc may be involved in. Besides MAPK activation, Shc is also
related to the phosphatidylinositol 3-kinase/Akt pathway [23],
c-Myc activation, [24], and the JNK signaling pathway [17].
Besides the EGF cascade, Shc was also reported to regulate
cascades of other growth factors, cytokines or hormones such
as estrogen [25], insulin-like growth factor-1 [26], and inter-
leukin 2 [27]. While our results suggest that Shc is redundant
in the EGF-EGFR stimulation of MAPK, they cannot easily
be extrapolated to other systems. However, it is safe to say
that Shc is redundant in the cases in which there exists alter-
native pathway(s) for the execution of the observed cell func-
tions; and it is non-redundant in the cases in which there are
no alternative pathway(s) for the cell to use for expressing
speci¢c phenotype(s). Perturbation or knockout experiments
could provide clues on the existence of alternative pathways
involved in the relevant cellular phenotypes.
The dominance of the Shc-dependent pathway during acti-
vation of MAPK was unexpected, considering that the Shc-
dependent pathway is longer than the Shc-independent path-
way. Also, this dominance, to our knowledge, has not yet
been observed experimentally and its biological meaning re-
Fig. 7. The level of the rate constant v41k1 determines the usage of two sub-pathways in the Shc-dependent pathway for producing Ras-GTP.
Time course of £uxes of reaction v24 and v25 (not shown) and v41 in 10 min at di¡erent values for rate constant k1 of reaction v41. Simula-
tion condition was the same as described in Fig. 5, except v41k1 was scanned and the £uxes of reactions v24 and v41 were traced. Note that at
di¡erent v41k1 values, di¡erent sub-pathways could be used in the Shc-dependent pathway.
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mains unknown. While one possibility is that activation of
MAPK via the Shc-dependent pathway could be more e⁄-
cient (i.e. resulting in larger ampli¢cation of the signal) than
via the Shc-independent pathway, the result of Shc concentra-
tion scanning experiments (Fig. 3) does not support this. The
real roles Shc plays in physiological and pathological process-
es can only be ¢gured out with larger-scale and more detailed
models. However, our hypothesis is that the importance of its
dominance might not reside in EGFR activation of Ras-GTP
itself. Rather, it might increase the competition of this activa-
tion with other receptor-induced pathways in which Shc is
also involved. Besides, an interesting conclusion implied by
this result is that, during MAPK activation by EGFR, the
longer pathway (Shc-dependent), instead of the shorter path-
way (Shc-independent), is preferentially used. Further exper-
imental results are needed to con¢rm this computational in-
ference. A possible experimental strategy is to measure the
contents of the molecular species with newly developed tech-
niques such as mass spectrometry-based proteomics. In a re-
cent study, this methodology was applied to analyze the pro-
teins from HeLa cells treated with EGF, and absorbed by
immobilized Grb2 fusion protein [28]. Although increases in
proteins absorbed by the Grb2 SH2 domain were observed,
similar yet more quantitative (e.g. put the labeled proteins as
inner references) experiments in a time series will be more
informative.
As demonstrated, the key steps determining the dominance
of the Shc-dependent pathway are Shc binding and phosphor-
ylation by EGFR (rate constants v22k1 and v23k1). Three
isoforms of Shc (46 kDa, 52 kDa and 66 kDa) could be ex-
pressed in the cells, and the major substrates for EGFR are 46
kDa and 52 kDa Shc (phosphorylated to similar extents), very
limited 66 kDa Shc was phosphorylated by EGFR [29]. The
parameters in the model used in this study were based on the
kinetics of the 46 and 52 kDa Shc isoforms [11]. Thus, if the
66 kDa Shc is the predominant or exclusive isoform, utiliza-
tion of the two pathways could be di¡erent from the modeling
result, and it is possible for them to be utilized to a similar
extent. However, more accurate modeling demands the di¡er-
entiation of the Shc isoforms at the kinetic level.
While there might be more sub-pathways in the Shc-depen-
dent pathway, via v37, v39 and v32, they are not considered
important under the current modeling situation. First, all of
them need phosphorylated Shc (Shc*) or complexes contain-
ing Shc* and thus they are dependent on v22 and v23. Second,
£ux-tracing results showed that they were all involved in the
dissociation, instead of formation, of the intermediates of the
Shc-dependent pathway (data not shown). Interestingly, in
some tumor cells, Shc was constitutionally phosphorylated,
because of the constitutionally activated tyrosine kinases
[30]. Under those circumstances, the alternative sub-pathways
might be used in Ras-GTP production. However, detailed
modeling needs extra and/or renewed initial state variables.
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